Drug firm Wockhardt today reported over two-fold increase in consolidated net profit at Rs 428 crore for the third quarter ended December 31, 2012, on robust sales across international markets, including US. The company had posted a net profit of Rs 213 crore in the same period of previous fiscal.
Consolidated net sales of the company rose to Rs 1,435 crore in the third quarter from Rs 1,141 crore in the corresponding period of 2011—12 fiscal.
The Mumbai-based firm said its international business contributed 83 per cent of the total revenues during the quarter.
“Wockhardt’s US business recorded a growth of 45 per cent compared to the corresponding quarter of 2011—12 fiscal,” it said.
During the period under review, the company said its UK business recorded a growth of 19 per cent compared to the corresponding quarter of previous fiscal.
The company’s India business grew by 14 per cent and the emerging markets business grew by 18 per cent compared to the corresponding quarter of 2011-12 fiscal, it said.
Shares of Wockhardt today closed at Rs 1,728.75 on the BSE, down 2.12 per cent from their previous close.